Nisa Investment Advisors
AXDX

Nisa Investment Advisors’s Accelerate Diagnostics AXDX Stock Holding History

Nisa Investment Advisors’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-30
Closed – – 2377
2022
Q1 		$0 Sell
30
-673
-96% -$19.2K ﹤0.01% 2357
2021
Q4 		$23K Buy
703
+673
+2,243% +$37.5K ﹤0.01% 1896
2021
Q3 		$2 Hold
30
– – ﹤0.01% 2289
2021
Q2 		$2 Sell
30
-15
-33% -$1.19K ﹤0.01% 2302
2021
Q1 		$4 Buy
+45
New +$4.57K ﹤0.01% 2264

Other funds holding AXDX

GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
CIA
Cladis Investment Advisory Billings, Montana $182M AUM 33.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $2.74B AUM 20.71% 1-Year Est. Return

Nisa Investment Advisors's AXDX Position: Q2 2022 in Review

Nisa Investment Advisors sold out of Accelerate Diagnostics (AXDX) in Q2 2022, closing a stake of 30 shares.

Nisa Investment Advisors first reported a position in AXDX in Q1 2021 and held it in 5 quarters. The position peaked at $23K in Q4 2021. 74 funds tracked by Wall St. Rank hold AXDX as of Q2 2022.

  • Nisa Investment Advisors reported no remaining Accelerate Diagnostics position as of Q2 2022 after selling out during the quarter.
  • Nisa Investment Advisors sold 30 Accelerate Diagnostics shares in Q2 2022.
  • Nisa Investment Advisors first reported a position in Accelerate Diagnostics in Q1 2021 and held it in 5 quarters.
  • Nisa Investment Advisors's Accelerate Diagnostics position peaked at $23K in Q4 2021.
  • 74 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2022.

Based on Nisa Investment Advisors's 13F filing for Q2 2022, filed 3 Aug 2022.